| scholarly article | Q13442814 |
| P50 | author | Paolo Muiesan | Q59829883 |
| P2093 | author name string | Portmann BC | |
| Williams R | |||
| Heneghan MA | |||
| O'Grady JG | |||
| Heaton ND | |||
| Rela M | |||
| Norris SM | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autoimmune hepatitis | Q786844 |
| liver transplantation | Q1368191 | ||
| P304 | page(s) | 464-470 | |
| P577 | publication date | 2001-09-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults | |
| P478 | volume | 34 |
| Q42271695 | "Plasma cell hepatitis" in liver allografts: identification and characterization of an IgG4-rich cohort |
| Q81726104 | AASLD practice guidelines: Evaluation of the patient for liver transplantation |
| Q46874610 | Anti-interleukin 2 receptor antibodies and mycophenolate mofetil for treatment of steroid-resistant rejection in adult liver transplantation. |
| Q39212663 | Autoimmune Hepatitis in the Liver Transplant Graft |
| Q92314377 | Autoimmune Hepatitis-Immunologically Triggered Liver Pathogenesis-Diagnostic and Therapeutic Strategies |
| Q86886381 | Autoimmune hepatitis |
| Q86954391 | Autoimmune hepatitis |
| Q34661366 | Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance |
| Q34936578 | Autoimmune hepatitis in children |
| Q33342074 | Autoimmune hepatitis, from mechanisms to therapy |
| Q36574524 | Autoimmune hepatitis--approach to diagnosis. |
| Q37346057 | Autoimmune hepatitis. Part B: diagnosis |
| Q33977201 | Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management |
| Q77721792 | Autoimmune liver disease |
| Q36826185 | Beyond five years: long-term follow-up in pediatric liver transplantation |
| Q37425999 | Chronic liver allograft dysfunction |
| Q37106402 | Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly |
| Q36250837 | Could post-liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis? |
| Q37503380 | Current and future treatments of autoimmune hepatitis |
| Q34615157 | Current therapy for autoimmune hepatitis |
| Q59359557 | De Novo Autoimmune Hepatitis Following Liver Transplantation |
| Q42795512 | De Novo Autoimmune Hepatitis With Centrilobular Necrosis Following Liver Transplantation for Primary Biliary Cirrhosis: A Case Report |
| Q38973707 | De novo autoimmune hepatitis after liver transplantation: A focus on glutathione S-transferase theta 1. |
| Q79781897 | De novo autoimmune hepatitis following liver transplantation for primary biliary cirrhosis |
| Q46449483 | De novo autoimmune hepatitis following liver transplantation: a case report |
| Q26766082 | De novo autoimmune hepatitis in liver transplant: State-of-the-art review |
| Q44715107 | Development of autoantibodies after pediatric liver transplantation. |
| Q28076505 | Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions |
| Q92166689 | Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the study of liver diseases |
| Q37969669 | Diagnosis and treatment of autoimmune hepatitis |
| Q38007886 | Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation |
| Q53191503 | Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease. |
| Q36668891 | Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting |
| Q45045579 | Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation |
| Q35212334 | Immunological dysfunction during or after antiviral therapy for recurrent hepatitis C reduces graft survival |
| Q51331002 | Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation. |
| Q33948215 | Juvenile autoimmune hepatitis: Spectrum of the disease |
| Q36548482 | Liver biopsy interpretation for causes of late liver allograft dysfunction |
| Q35066577 | Liver transplantation and autoimmune hepatitis |
| Q38123133 | Liver transplantation and autoimmune liver diseases |
| Q73631442 | Liver transplantation for primary biliary cirrhosis |
| Q35182259 | Liver transplantation for primary biliary cirrhosis: indications and risk of recurrence |
| Q53259695 | Long-term outcomes of de novo autoimmune hepatitis in pediatric liver transplant recipients. |
| Q46721489 | Post-liver transplantation de novo hepatitis with overlap features |
| Q83182729 | Progressive histological damage in liver allografts following pediatric liver transplantation |
| Q34941664 | Recurrence of primary biliary cirrhosis and development of autoimmune hepatitis after liver transplant: A blind histologic study |
| Q58798093 | Rethinking immune hepatitis, an old concept for liver allograft rejection: Relevance of glutathione S-transferase T1 mismatch |
| Q37182962 | Transplantation in autoimmune liver diseases |
| Q80164148 | [Histopathology in liver transplantation] |
Search more.